Home
Reprogramming immunity
We are mapping the immune system at unprecedented scale & granularity to develop the next-generation of immunomodulatory therapeutics.
Platform
Our therapeutics engine is powered by AMICA™, our Annotated Multiomic Immune Cell Atlas , which combines multi-omic single cell analysis with machine learning and functional genomics.
Therapeutics
Immunai is leveraging our technology platform and patient-derived multi-omic data to drive target and therapeutic discovery.
To accomplish our mission, we forge partnerships with biopharmaceutical companies and academic research institutions at various stages of the drug discovery & development process.
Our Company
Immunai was founded on the belief that immunomics and machine learning could unlock the next generation of immunomodulatory drugs. Learn more about our Founding Story.
We are a multidisciplinary team of immunologists, engineers, drug developers, computer scientists, and entrepreneurs singularly focused on bringing breakthrough medicines to patients. We combine an engineering-first approach and a deep understanding of the immune system to find and validate targets and therapeutics.